Nature's Sunshine Products, Inc.

Nature's Sunshine Products, Inc. (NASDAQ: NATR) operates as a natural health and wellness company engaged in the manufacturing and direct selling of nutritional and personal care products. The company maintains its website at www.natr.com and serves customers across multiple continents through a network of independent consultants who market products using direct selling techniques.

The company maintains four reportable business segments organized by geographic region: Asia, Europe, North America, and Latin America and Other. The Latin America and Other segment includes wholesale operations where the company grants distribution rights to locally-managed entities. In 2025, approximately 72.2 percent of net sales were generated outside the United States, with the majority recognized in local currencies across international markets.

Nature's Sunshine Products manufactures and distributes over 800 products across six primary categories: general health, immune support, cardiovascular, digestive, personal care, and weight management. The company formulates, encapsulates, tablets, and concentrates herbs and raw materials sourced in bulk, with most products manufactured at its facility in Spanish Fork, Utah. Additional manufacturing occurs through contract manufacturers operating under company specifications. The company operates regional warehouses in Georgia, Ohio, and Texas to support U.S. operations, while many international operations maintain their own warehouse facilities.

The company operates under two primary brand names: Nature's Sunshine Products and Synergy WorldWide. These brands hold trademark registrations across the United States and numerous other countries, with registration durations typically ranging from ten to twenty years depending on jurisdiction.

As of December 31, 2025, the company employed 806 individuals globally. The company conducts research and development activities at its Hughes Center for Research and Innovation located at its corporate offices in Lehi, Utah, with principal emphasis on clinical research supporting new product development and enhancement of existing offerings.

The company's business model relies on independent consultants who receive volume incentives based on personal product sales and their sales organization's performance. In China, the company pays independent service fees rather than volume incentives. The direct selling distribution channel represents the company's primary competitive advantage, supported by product quality, consultant training, and financial incentive programs.